Covid-19 in children
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Aged 0-17 years at COVID-19 diagnosis, AND - Presented to an emergency or outpatient department of a Dutch hospital and/or admitted to hospital, AND - Diagnosed with COVID-19 in his/her medical history, based on at least one positive real-time RT-PCR test on nasopharyngeal, oropharyngeal, sputum or fecal sample for SARS-CoV-2 OR fulfilled a clinical diagnosis of COVID-19, should testing of SARS-CoV-2 yield inconclusive results and/or if testing is no longer possible due to lack of reagents, AND - Enrolled in the COPP study (Clinical features of COVID-19 in Pediatric Patients (23)), with specific consent to be approached for follow-up studies.
Exclusion criteria
Exclusion criteria: - Consent from guardians and/or patient is not received, or - Consent for COPP study data access is not received
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To describe potential pulmonary sequelae, in particular symptoms, the need for hospital care, at 6 to 12-months following a COVID-19 diagnosis among pediatric patients receiving care in the hospital or outpatient setting in the Netherlands. -To determine risk factors for pulmonary sequelae among COVID-19 hospitalized and outpatient pediatric patients in the Netherlands. | — |
Secondary
| Measure | Time frame |
|---|---|
| - To describe lung function in the follow-up of children with COVID-19. - To describe exhaled breath profiles in children with a history of COVID-19 - To assess the quality of life in children with a history of COVID-19. - To describe CT abnormalities in patients with chronic respiratory complaints and/or pulmonary function test abnormalities and a history of COVID-19. | — |
Contacts
Amsterdam UMC, locatie AMC